NetworkNewsBreaks – TearLab Corp. (NASDAQ: TEAR) Shares Skyrocket on Regulatory Approval of Commercial TearLab Discovery™ System in EU

TearLab (NASDAQ: TEAR) shares are up 84% mid-day following news that the company’s commercial version of its TearLab Discovery™ System has met all the applicable provisions of In Vitro Diagnostic Medical Devices Directive 98/79 EC required for CE Marking. Regulatory clearance enables the company the ability to market in the European Union and European Free Trade Association member countries and expands regulatory clearance beyond the previously-cleared discovery device to include the first commercial test card. The company is expected to use this clearance to build a clinical data package in support of a 510(k) submission to the FDA, which is expected in the second half of 2017. “The CE mark for the TearLab Discovery(TM) platform represents a breakthrough in ophthalmic diagnostic technology and will help usher in a new era in eye care that leverages the power of molecular diagnostics at the point of care, which has long been standard of care in other medical specialties to both diagnose diseases and guide treatment,” TearLab CEO Seph Jensen stated in the news release.

To view the full press release, visit:

About TearLab Corporation

TearLab Corporation develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System.  TearLab Corporation’s common shares trade on the NASDAQ Capital Market under the symbol ‘TEAR’ and on the Toronto Stock Exchange under the symbol ‘TLB’. For more information, visit

About NetworkNewsBreaks

NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s